ConductScience.org, home

Gene · 10657

NIH grants1,208

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKHDRBS1 papersNewest fiscal year
P30CA091842Cancer Center Support Grant22025
P30CA142543UT Southwestern Medical Center Simmons Comprehensive Cancer Center22025
R01HL128239Genetic and molecular basis for SRSF2 mutations in myelodysplasia22025
R01NS027036Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias22025
R01NS103172Therapeutic strategies for microsatellite expansion diseases using RNA targeting22025
R01NS110100Trajectories and Markers of Neurodegeneration in Carriers of the Fragile X Premutation22025
R35GM118136Regulation of mRNA processing: Mechanisms and Consequences22025
R35NS116846Design of Precision Small Molecules Targeting RNA Repeating Transcripts to Manipulate and Study Disease Biology22025
ZIAAG000394Post-transcriptional regulation of energy usage: glucose and lipid metabolism22025
ZIADK015602Chromatin Insulator Function and Nuclear Organization22025
ZIADK057808Understanding the mutational mechanism responsible for the Repeat Expansion Diseases22025
ZIASC010357Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses22025
K01NS126736FXTAS Key Molecular Pathways Converge with Other Neurodegenerative Disorders12025
K08HL157700A BRD4-GATA4 module cooperatively regulates mitochondrial bioenergetic homeostasis in the adult heart12025
K12HD000849Reproductive Scientist Development Program12025
P01CA100730Retrovirus Models of Cancer12025
P01CA120964Molecular Pathogenesis of the Hamartoma Syndromes12025
P01CA214091Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies12025
P20GM103451New Mexico IDeA Networks of Biomedical Research Excellence (INBRE)12025
P20GM121176Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10657/grants?page=2